More News! 25 Mar 2019 Swedish Biotech’s Stock Severely Hit by Failure of Biogen’s Alzheimer’s Drug …begun a phase III trial of its own Alzheimer’s treatment. Last week, Biogen and its pharma collaborator Eisai discontinued the phase III development of an antibody drug for Alzheimer’s disease… March 25, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 19 Jan 2024 Re-coding the brain: Is CRISPR capable of curing neurodegenerative diseases? …disease. Two CRISPR-based approaches for Alzheimer’s disease unveiled at Alzheimer’s Association International Conference At the Alzheimer’s Association International Conference (AAIC) in Amsterdam last year, researchers unveiled two methods of utilizing… January 19, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2022 Japanese scientists find way to detect characteristic of Alzheimer’s disease from blood samples …in the brain with age. In addition to the lack of effective treatments of Alzheimer’s, there are few methods to diagnose Alzheimer’s. Alzheimer’s can only be definitively diagnosed by direct… October 7, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 28 May 2019 Viral Vaccines Could Be Weapons Against Alzheimer’s Disease …of harmful amyloid fibrils that play a part in Alzheimer’s disease. In spite of the problematic history of Alzheimer’s disease treatments, Ezzat is confident that viral vaccines can provide a… May 28, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jul 2023 Could a natural sweetener from hydrangeas treat Alzheimer’s disease? …in treating Alzheimer’s disease. Going ahead, these results can provide important clues for the development of effective treatment for AD. Alzheimer’s disease is the most common neurodegenerative disorder in the… July 28, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 22 Jun 2023 Alchemab Therapeutics unveils Alzheimer’s candidate …we hope could be a new therapy for Alzheimer’s. While there’s been progress in the Alzheimer’s field in the last few years, there’s still a tremendous need for more and… June 22, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 25 May 2023 Researchers discover genetic variation offers Alzheimer’s disease clues …beta-amyloidogenic processing of APP may be a feasible strategy for the prevention of Alzheimer’s disease. Alzheimer’s disease is the most common form of dementia with more than 40 million affected… May 25, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 2 Sep 2021 AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research …Alzheimer’s patients, though the firm claimed success in a small group of patients that took no other Alzheimer’s medication. Results from another phase III trial are expected next year. One… September 2, 2021 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 30 Dec 2020 A Look Back at the Past Decade of European Biotech …a state matter. The state will make sure that we have enough options to deal with deadly bacteria.’ Alzheimer’s research The last decade saw hundreds of clinical trials for Alzheimer’s… December 30, 2020 - 15 minutesmins - By Karen O’Hanlon Cohrt Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Apr 2023 6 new vaccines being developed for difficult-to-treat diseases …In this article, we explore six new vaccines in clinical development for difficult-to-treat diseases. Table of contents UB-311: Vaccine for Alzheimer’s disease Alzheimer’s disease is notoriously difficult to treat, and… April 12, 2023 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 26 Sep 2016 UPDATE: AC Immune rakes in €52.5M IPO for assault on Alzheimers It’s not the $700M headlines imply, but AC Immune is winding up to make a splashy IPO of €52.5M to establish itself in the Alzheimer’s Disease space. You might have… September 26, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jan 2018 British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s …blood-brain barrier. Neurodegenerative diseases are a hot topic, with age-related diseases like Alzheimer’s and Parkinson’s rising in prevalence. In the US alone, 5 million people suffer from Alzheimer’s disease, 1… January 15, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email